Showing 1 to 1 of 1 results
theguardian.com
🌐 90% Global Worthiness


Gene Therapy Shows Promise in Frontotemporal Dementia Trials
A British company, AviadoBio, is conducting clinical trials of a gene therapy (AVB-101) for frontotemporal dementia (FTD-GRN), a genetic form of dementia, infusing a functional gene copy directly into the brain to restore progranulin protein levels; early trial data is expected next year.
Gene Therapy Shows Promise in Frontotemporal Dementia Trials
A British company, AviadoBio, is conducting clinical trials of a gene therapy (AVB-101) for frontotemporal dementia (FTD-GRN), a genetic form of dementia, infusing a functional gene copy directly into the brain to restore progranulin protein levels; early trial data is expected next year.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results